Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581477 · ClinicalTrials.gov registry record · Phase 2
Treatment of Orthostatic Hypotension
A Phase 2 study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT00581477 is a Phase 2 study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 8 participants.
The verdict
NCT00581477, a Phase 2 study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to try different medications in patients with low blood pressure and other problems with their involuntary (autonomic) nervous system. The pharmacological trials in this study will perhaps lead to more effective treatment. The protocol includes single dose trials, dose-selection trials, 5-day trials and chronic (approximately 2 months) trials, although only dose-selection trials were consistently performed and have results presented.
Interventions
- DRUG Droxidopa Oral Product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2004-01 |
| Est. Completion | 2020-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581477
The ClinicalTrials.gov registry entry for NCT00581477 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Droxidopa Oral Product is the first listed.
NCT00581477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00581477 about?
NCT00581477 is a clinical study titled "Treatment of Orthostatic Hypotension". The purpose of this study is to try different medications in patients with low blood pressure and other problems with their involuntary (autonomic) nervous system. The pharmacological trials in this study will perhaps lead to more effective treatment. The protocol includes single dose trials, dose-s...
What is the current status of trial NCT00581477?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2004-01. Estimated completion is 2020-12.
What interventions are being tested in trial NCT00581477?
The interventions under investigation include: Droxidopa Oral Product (DRUG).
Who is sponsoring clinical trial NCT00581477?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.